Strategic Vision: A Global Pharma Company

Progress on US Injectables Pipeline Nanomi Pipeline Product (Market Size)¹ Risperdal Consta Depot 2 Formulation Clinical Phase Depot 3 LRP Complex injectables Pipeline Product Name (Market Size)¹ Product 1 Product 2 Product 3 Product 4 Filing LUPIN Risperidone is at end of clinical phase Depot 2 and Depot 3 are at end of formulation development stage API/RM/PM sourcing Q1/Q2 status Formulation and characterization Validation Registration batches Clinical Submission Product 1 has been filed Product 2,3 & 4 are at clinical stage Complex Injectables market size US$ 4.8 bn in depot; >US$ 17.5 bn in other complex injectables 1. IQVIA MAT Mar 2022 17

View entire presentation